JPost.com - Israel's Pfizer Vaccine - Tracker and News

Recordando los años más productivos de Morris Kahn - opinión

BY STAN POLOVETS — Mon, 16 Mar 2026 16:12:19 GMT

El fundador del Premio Génesis Stan Polovets explica por qué tus años setenta, ochenta e incluso noventa pueden ser tus años más impactantes.

'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion

BY STAN POLOVETS — Fri, 02 Jan 2026 08:37:49 GMT

Founder of the Genesis Prize Stan Polovets on why your seventies and eighties – and even nineties – can be your most impactful years.

Grapevine, November 30, 2025: Mamdani complexities

BY GREER FAY CASHMAN — Sun, 30 Nov 2025 04:39:25 GMT

Movers and shakers in Israeli society.

MBS’s first Washington trip since 2018 brings new investments

BY REUTERS AND JERUSALEM POST STAFF — Thu, 20 Nov 2025 09:32:05 GMT

US–Saudi investments unveiled on Wednesday, one day earlier, during MBS’s first Washington visit since 2018.

Former Pfizer chief scientist joins Immunai’s board of directors

BY MAARIV ONLINE — Sun, 23 Mar 2025 13:45:00 GMT

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the appointment of Dr. Mikael Dolsten to its board of directors.

Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors

BY JERUSALEM POST STAFF — Sun, 09 Mar 2025 12:03:14 GMT

Dolsten brings decades of pharmaceutical leadership to advance AI-driven drug discovery.

Israel Bonds honors Pfizer CEO Albert Bourla for contributions to health, support for Israel

BY JERUSALEM POST STAFF — Thu, 23 May 2024 04:04:35 GMT

Bourla has received several honors from Israeli institutions in recognition of his support for Israel and his contributions to medicine.

Grapevine January 31, 2024: The courage of her convictions

BY GREER FAY CASHMAN — Wed, 31 Jan 2024 04:21:26 GMT

Movers and shakers in Israeli society.

Israeli-American blueprint for future pandemic medications

BY JUDY SIEGEL-ITZKOVICH — Fri, 10 Nov 2023 16:18:15 GMT

An open-access format for drug discovery is helping design medications at lower prices against potential viral threats to mankind.

Antibiotic shortages expected to worsen syphilis epidemic - NYT

BY JERUSALEM POST STAFF — Mon, 10 Jul 2023 05:13:06 GMT

Pfizer announced that there would be shortages of Bicillin L-A last month. Bicillin L-A is a long-acting injectable antibiotic that is also known as penicillin G benzathine.

Pfizer scraps one weight loss drug in race to develop Ozempic rival

BY REUTERS — Mon, 26 Jun 2023 16:36:48 GMT

The company's shares fell 3.5% in volatile premarket trading on Monday as Pfizer said it would stop developing its therapy lotiglipron.

Pfizer expects to run out of antibiotic supply soon

BY REUTERS — Tue, 13 Jun 2023 21:19:48 GMT

Supply of the drug, Bicillin L-A, is expected to be exhausted by the end of this quarter, the company said in a letter to the US health regulator dated Monday.

Pfizer pouring COVID profits into cancer battle, CEO Bourla says

BY REUTERS — Thu, 11 May 2023 20:13:44 GMT

The COVID products drove Pfizer's revenue to record levels, topping $100 billion in 2022 and $80 billion in 2021.

Got migraines? FDA approved Pfizer's nasal spray treatment

BY WALLA! HEALTH — Fri, 21 Apr 2023 17:54:26 GMT

Every day, there are 40,000 migraine attacks in Israel. This new Pfizer treatment could help

Arbutus files patent infringement lawsuit against Pfizer/BioNTech over COVID shots

BY REUTERS — Tue, 04 Apr 2023 16:44:13 GMT

The lawsuit by Arbutus and Genevant says Pfizer/BioNTech engaged in licensing discussions for the technology but they did not "result in a settlement."

Pfizer's COVID vaccine factory: Witnessing a modern miracle

BY MAAYAN JAFFE-HOFFMAN — Sat, 25 Mar 2023 22:22:51 GMT

Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.

Sleeping less than six hours will decrease vaccine effectiveness - study

BY JERUSALEM POST STAFF — Mon, 13 Mar 2023 20:25:23 GMT

The multi-institution study, published in the peer-reviewed academic journal Current Biology, sheds light on the link between sleep duration and antibody response.

mRNA could make flu vaccines more effective - here's how

BY MAAYAN JAFFE-HOFFMAN — Mon, 13 Mar 2023 11:31:28 GMT

The World Health Organization reported that as many as 5 million people suffer from severe cases of influenza each year.

Could vaccines be a cure for antibiotic-resistant bacteria?

BY MAAYAN JAFFE-HOFFMAN — Sat, 11 Mar 2023 12:48:06 GMT

Israeli scientists announce 100% effectiveness of mRNA vaccine against Black Plague-causing bacteria in preclinical trial performed on mice.

‘Hindsight is 20/20’: Israel's lessons after 3 years of COVID-19

BY MAAYAN JAFFE-HOFFMAN — Fri, 17 Feb 2023 12:44:46 GMT

HEALTH AFFAIRS: On Israel’s three-year COVID anniversary, ‘czars’ look forward and back.

US Parkinson's disease incidence far higher than earlier estimates -study

BY REUTERS — Thu, 15 Dec 2022 22:50:27 GMT

Analysis of insurance claims and population growth indicates higher numbers than previously thought - and they will continue to rise.

NYSE gala honors Pfizer, Teva Pharmaceuticals, Silverstein Properties, Azrieli Group

BY JERUSALEM POST STAFF — Tue, 15 Nov 2022 04:42:14 GMT

Israel Day, organized and hosted by the America-Israel Friendship League and Israeli Mapped in NY annually holds the event in collaboration with the NY Stock Exchange to honor Israeli tech

Couple who stopped COVID-19 promise cancer vaccine by 2030

BY LIHI SHORESH/WALLA! — Wed, 26 Oct 2022 09:13:10 GMT

These two doctors developed one of the vaccines against COVID-19. It's believed that they will succeed in developing a vaccine against specific cancers in the next eight years.

New Omicron vaccines proven safe and effective

BY JUDY SIEGEL-ITZKOVICH — Thu, 20 Oct 2022 16:03:55 GMT

The new boosters are suited to two COVID-19 strains of the Omicron virus variant that represents the vast majority of infections, according to the FDA.

COVID: Omicron BA.2 infection after vaccine can protect from BA.4/BA.5 - study

BY AARON REICH — Tue, 20 Sep 2022 18:26:03 GMT

Breakthrough infections of COVID-19 Omicron BA.2 in people who have received the Pfizer/BioNTech vaccine have more antibodies against the dominant BA.4/BA.5 descendants.

Israel's COVID-19 czar fears new wave combined with flu, urges vaccines

BY JUDY SIEGEL-ITZKOVICH — Wed, 14 Sep 2022 16:04:02 GMT

Israel's COVID-19 czar Prof. Salman Zarka calls for the voluntary wearing of face masks in risky places and antigen testing as the Jewish High Holy Days approach.

COVID-19 vaccines can significantly reduce long-COVID risk - Israeli study

BY JUDY SIEGEL-ITZKOVICH — Thu, 08 Sep 2022 11:00:07 GMT

A new study from Bar-Ilan University shows that eight of the 10 most commonly reported symptoms were reported between 50% and 80% less often among those who received at least two vaccine doses.

Top scientists join forces to study leading theory behind long COVID

BY REUTERS — Thu, 08 Sep 2022 08:01:17 GMT

A new research group is gathering top scientists to streamline research and quickly pivot to clinical trials of potential treatments for long COVID.

COVID-19: Health Min. offers non-mRNA vaccine, alt. for Pfizer, Moderna

BY JUDY SIEGEL-ITZKOVICH — Sun, 04 Sep 2022 17:33:12 GMT

It has obtained supplies of Nuvaxovid from the Novavax company. It is a vaccine that protects against serious complications of the pandemic without being based on mRNA.

Pfizer, Moderna's COVID-19 Omicron vaccine boosters approved by US FDA

BY REUTERS — Wed, 31 Aug 2022 17:46:28 GMT

Pfizer said it has some doses ready to ship immediately and can deliver up to 15 million doses by September 9.